Related Experiment Video
Updated: Jun 19, 2026
09:05
Generation and Quantitative Analysis of Pulsed Low Frequency Ultrasound to Determine the Sonic Sensitivity of Untreated and Treated Neoplastic Cells
Published on: July 22, 2015
Advances in Sonodynamic Therapy: Focus on Ferroptosis
Wendi Su1, Hao Wang1, Juhong Pan1
1Echo Lab, Department of Ultrasound Imaging, Renmin Hospital of Wuhan University, Wuhan 430060, China.
Journal of Medicinal Chemistry
|March 10, 2025
Summary
Sonodynamic therapy (SDT) offers a promising, noninvasive approach to regulate ferroptosis, a crucial cell death pathway. Targeted SDT drug delivery platforms enhance treatment efficiency for various diseases.
Area of Science:
- Biomedical Engineering
- Oncology
- Cell Biology
Background:
- Ferroptosis is a nonapoptotic cell death mechanism identified in 2012.
- Noninvasive therapeutic strategies targeting ferroptosis are critical for managing diverse diseases.
- Sonodynamic therapy (SDT) is a promising noninvasive treatment modality due to its deep tissue penetration and minimal side effects.
Purpose of the Study:
- To review the fundamental mechanisms and influencing factors of SDT.
- To highlight the significance of ferroptosis-targeted SDT for therapeutic applications.
- To summarize recent advancements in ferroptosis-targeted SDT and novel ultrasound-responsive drug delivery systems.
Main Methods:
- Review of current literature on SDT and ferroptosis.
- Analysis of different pathways for ferroptosis-targeted SDT.
- Exploration of innovative composite ultrasound-responsive drug delivery platforms.
Main Results:
- SDT demonstrates potential for targeted regulation of ferroptosis.
- Targeted drug delivery platforms enhance SDT efficacy.
- Composite ultrasound-responsive platforms represent an innovative approach.
Conclusions:
- Ferroptosis-targeted SDT is a rapidly advancing field with significant therapeutic potential.
- Further research into advanced drug delivery systems can optimize SDT efficacy.
- SDT offers a promising avenue for noninvasive disease treatment by modulating ferroptosis.
